Andromeda Capital’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-103,560
Closed -$3.56M 31
2014
Q4
$3.56M Buy
+103,560
New +$3.38M 4.48% 10

Other funds holding AUXL

Andromeda Capital's AUXL Position: Q1 2015 in Review

Andromeda Capital sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 103,560 shares — an estimated $3.56M sold.

Andromeda Capital first reported a position in AUXL in Q4 2014 and held it in 1 quarter. The position peaked at $3.56M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Andromeda Capital reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Andromeda Capital sold 103,560 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $3.56M.
  • Andromeda Capital first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q4 2014 and held it in 1 quarter.
  • Andromeda Capital's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.56M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Andromeda Capital's 13F filing for Q1 2015, filed 15 May 2015.